COVID-19 and Cystic Fibrosis: Diagnostic Difficulties or Incorrect Methods?

ISSN: 0973-7510

E-ISSN: 2581-690X

Case Report | Open Access

Samuel Pecho-Silva^1,2, Ana Claudia Navarro-Solsol³,Vicky Panduro-Correa⁴, Kovy Arteaga-Livias^2,4,Alfonso J. Rodriguez-Morales^2,5,6 and Kuldeep Dhama⁷

¹Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.

²Universidad Científica del Sur. Lima, Peru.

³Universidad Nacional de Ucayali. Pucallpa, Peru.

⁴Facultad de Medicina, Universidad Nacional Hermilio Valdizan. Huanuco, Peru.

⁵Public Health and Infection Research Group, Faculty of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Risaralda, Colombia.

⁶Grupo de Investigacion Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Americas, Pereira, Risaralda, 660004, Colombia.

⁷Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly – 243 122, Uttar Pradesh, India.

J Pure Appl Microbiol. 2020;14(3):1681-1685 | Article Number: 6516

https://doi.org/10.22207/JPAM.14.3.06 | © The Author(s). 2020

Received: 20/05/2020 | Accepted: 07/07/2020 | Published: 22/07/2020

Read the full text ❯

Abstract

Cystic fibrosis (CF) is a chronic lung disease with wide distribution worldwide. With the appearance of the Coronavirus Disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), difficulties arise when evaluating, diagnosing, and treating patients with other conditions, including CF. We present the case of a patient with CF who had a definite serological diagnosis, a CT scan suggestive of SARS-CoV-2 infection/COVID-19, and a negative molecular test (RT-PCR), with rapid resolution of symptoms and early discharge. CF/SARS-CoV-2 comorbidity needs to be adequately studied and assessed in the context of the COVID-19 pandemic.

Keywords

Cystic fibrosis, COVID-19, SARS-CoV-2, Serological tests, pandemic, Peru, Latin America

Download PDF

Article Metrics

Article View: 4666

JPAM.14.3.06 (2081 downloads)

Share This Article

© The Author(s) 2020. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.